Vitalik Buterin sent 256 ETH to Session and SimpleX to support on-chain privacy.  He called privacy “hygiene” and said low-risk DeFi on Ethereum has become safer over time. Vitalik Buterin announced he donated 256 ETH total, split evenly between two privacy-focused messaging projects. He said encrypted messaging is now a core defense for digital privacy, [...]]]>Vitalik Buterin sent 256 ETH to Session and SimpleX to support on-chain privacy.  He called privacy “hygiene” and said low-risk DeFi on Ethereum has become safer over time. Vitalik Buterin announced he donated 256 ETH total, split evenly between two privacy-focused messaging projects. He said encrypted messaging is now a core defense for digital privacy, [...]]]>

Ethereum’s Vitalik Buterin Funds Two Projects Driving Digital Privacy

  • Vitalik Buterin sent 256 ETH to Session and SimpleX to support on-chain privacy. 
  • He called privacy “hygiene” and said low-risk DeFi on Ethereum has become safer over time.

Vitalik Buterin announced he donated 256 ETH total, split evenly between two privacy-focused messaging projects. He said encrypted messaging is now a core defense for digital privacy, and donated 128 ETH to each of two projects driving that goal. He named permissionless account creation and metadata privacy as the next hurdles for the messaging space. After that, he highlighted Session and SimpleX Chat as apps working toward those targets.

Decentralized routing is technically challenging, so teams struggle to deliver strong metadata protection across devices. In addition, multi-device support increases complexity. He added that problems such as Sybil resistance and protection against network abuse also increase security requirements when apps avoid phone numbers for signups.

ChatGPT said:Vitalik Buterin X post announcing 128 ETH donations to privacy messaging apps Session and SimpleX, explaining goals like permissionless accounts and metadata privacy, with a Session logo preview card below the text.Source:  X

Buterin said privacy work needs more review and public attention. He encouraged users to download and use privacy apps to understand their impact firsthand. Meanwhile, he noted these platforms are not finished and still require development work before they reach optimal device support and network abuse protection.

Buterin Calls Privacy “Hygiene” After Bank Data Alert

In a recent update, we covered, Buterin replied to a post that called data retention “the industrial pollution of our era.” The post referred to reports that JPMorgan Chase, Citi, and Morgan Stanley were told some client data may have been taken. Under that thread, Buterin wrote, “Privacy is not a feature. Privacy is hygiene.”

Source: X

With that line, he treated privacy as a basic requirement, not an extra tool in digital services. His remark linked the reported bank data exposure to ongoing concerns over how large institutions store and manage user information. The comment also matched his other public statements on encrypted messaging and metadata protection. By calling privacy hygiene, he set it alongside routine practices that should be present in any system that handles personal data.

Buterin Now Sees Low-Risk DeFi as Everyday Finance

Buterin has long talked about risk in decentralized finance as Ethereum’s ecosystem grew. In a recent post we discussed earlier, he said “low-risk defi can be for Ethereum what search was for Google,” pointing to products that focus on safety and simple yield rather than speculation.

He wrote that DeFi used to face two main obstacles: regulatory barriers and smart contract safety issues. According to him, both areas have improved as frameworks matured and code review standards tightened.

Source: X

Buterin added that, for many users, DeFi is already safer than traditional finance in some cases. His comment showed that low-risk DeFi has become safer over time, as stronger code reviews and clearer rules cut down on earlier security problems.

]]>
Market Opportunity
Ethereum Logo
Ethereum Price(ETH)
$3,290.51
$3,290.51$3,290.51
-1.23%
USD
Ethereum (ETH) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23